Overview
Dr. Richard E. Chaisson is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in epidemiology and in international health, both in the Johns Hopkins Bloomberg School of Public Health. His area of clinical expertise is infectious diseases, particularly tuberculosis and HIV/AIDS. Dr. Chaisson serves as the director of the Johns Hopkins University Center for Tuberculosis Research, and is the director of the Johns Hopkins Center for AIDS Research. He received his B.S. and M.D. degrees from the University of Massachusetts. He was an intern, resident, fellow and assistant professor of medicine at the University of California, San Francisco, prior to moving to Johns Hopkins. From 1988 to 1998 he was director of the Johns Hopkins AIDS Service, leading the inpatient Polk Service on Osler 8, a subacute care unit at Bayview Medical Center, and the outpatient Moore Clinic. His cohort studies of HIV and with his colleague Richard Moore made major contributions to understanding the treatment and outcomes of HIV disease. In 1991 he was appointed Medical Director of the Baltimore City Health Department Tuberculosis Clinic, establishing it as a leading program in TB control. He founded the Center for TB Research in 1998, which is one of the world's leading academic center for basic, clinical, applied, and epidemiologic investigations in TB and its control. Dr. Chaisson has conducted multiple trials of treatments and strategies to treat, prevent, and control TB, TB/HIV co-infection, and HIV. From 2002-2014 he led the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), and from 2011-2018 he was inaugural chair of the TB Transformative Science Group of the AIDS Clinical Trials Group. In 2022 he was awarded a $200 million cooperative agreement from USAID for SMART4TB, an international research consortium to study tools to end TB globally, working with partners from multiple institutions to implement research, strengthen local capacity, and drive policy change. Dr. Chaisson has been recognized with numerous honors, including the HIV/AIDS Warrior Award from AIDS Action Baltimore in 2022, a Lifetime Achievement Award from the International Union Against TB and Lung Disease North American Region in 2021, election to the Association of American Professors in 2016, the Champions of TB Control Award from the U.S. Agency for International Development (USAID) in 2014 and the American Thoracic Society's World Lung Health Award in 2006.
Dr. Chaisson is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), and Sepsis.
His clinical research consists of co-authoring 193 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 76 articles in the study of HIV/AIDS.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.
Johns Hopkins Bayview Medical Center
Dr. Trevor Crowell is an adjunct assistant professor at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS, sexually transmitted infections, and other infectious diseases. Dr. Crowell earned his M.D. from the University of Southern California Keck School of Medicine and his Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He completed his residency at Case Western Reserve University/University Hospitals Case Medical Center and completed a fellowship in infectious diseases at Johns Hopkins. In addition to serving as a staff physician at Bayview Medical Center, Dr. Crowell is an Associate Director at the U.S. Military HIV Research Program, Walter Reed Army Institute of Research. He is also an assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Crowell is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Gonorrhea, Sepsis, and Chlamydia.
Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HIV/AIDSDr. Chaisson isDistinguished. Learn about HIV/AIDS.
- Experienced
- SepsisDr. Chaisson isExperienced. Learn about Sepsis.
- Severe Acute Respiratory Syndrome (SARS)Dr. Chaisson isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).